8:04 am Celsion announces FDA clearance of the OPTIMA study – a Pivotal Phase III trial of ThermoDox in primary liver cancer
View todays social media effects on CLSN
View the latest stocks trending across Twitter. Click to view dashboard
View todays social media effects on CLSN
View the latest stocks trending across Twitter. Click to view dashboard